First Clinical Use of CRISPR in the U.S.

Published 2019-07-30

The first clinical use of genetic cell manipulation using CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has been performed in the United States. A patient with Sickle Cell Anemia received autologous CRSPR edited Red Blood Cells producing fetal hemoglobin following chemotherapy at Sarah Cannon Research Institute in Nashville, Tennessee.